{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/42577"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/42577","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Using multiplex IHC to identify myeloid derived suppressor cells and antigen presenting cells in NSCLC","abstract":"Lung cancer is considered one of the deadliest cancers worldwide, with a five-year survival rate of under 20% [8]. There are three different categories of NSCLC tumors: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. The most common of the tumor types is adenocarcinoma [13]. Different cell types that make up the tumor microenvironment contribute to the treatment response and prognosis of the disease. Myeloid-derived suppressor cells (MDSCs) have been shown to be increased in cancer patients compared to healthy individuals. These cells are immunosuppressive and there is evidence that MDSCs play a role in drug resistance, tumor metastases, and suppression of immune cells in cancer [3]. Antigen presenting cells (APCs) are immune cells that present antigens to B cells, macrophages, and dendritic cells. Tumors can become resistant to immunotherapy by evading T cells through modulating antigen presentation by surface MHC (major histocompatibility complex) [7]. APCs use MHC to present antigens and interact with T cells. This interaction influences T cell activation and differentiation [4]. Characterizing differences in MDSCs and APCs between normal lung samples and NSCLC samples may be helpful in identifying mechanisms of tumor progression and treatment resistance. Multiplex IHC (immunohistochemistry) is a useful technique for the identification of MDSCs and APCs and it allows for the visualization of spatial relationships between these cell types and the tumor cells.","abstract_html":"Lung cancer is considered one of the deadliest cancers worldwide, with a five-year survival rate of under 20% [8]. There are three different categories of NSCLC tumors: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. The most common of the tumor types is adenocarcinoma [13]. Different cell types that make up the tumor microenvironment contribute to the treatment response and prognosis of the disease. Myeloid-derived suppressor cells (MDSCs) have been shown to be increased in cancer patients compared to healthy individuals. These cells are immunosuppressive and there is evidence that MDSCs play a role in drug resistance, tumor metastases, and suppression of immune cells in cancer [3]. Antigen presenting cells (APCs) are immune cells that present antigens to B cells, macrophages, and dendritic cells. Tumors can become resistant to immunotherapy by evading T cells through modulating antigen presentation by surface MHC (major histocompatibility complex) [7]. APCs use MHC to present antigens and interact with T cells. This interaction influences T cell activation and differentiation [4]. Characterizing differences in MDSCs and APCs between normal lung samples and NSCLC samples may be helpful in identifying mechanisms of tumor progression and treatment resistance. Multiplex IHC (immunohistochemistry) is a useful technique for the identification of MDSCs and APCs and it allows for the visualization of spatial relationships between these cell types and the tumor cells.","abstract_has_math":false,"creators":["King, Catherine"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Pathology","degree_department":null,"school":null,"contributors":[],"advisors":["Duffy, Elizabeth"],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021","date_published":"2021","updated_at":"2026-11-18T20:28:34Z","subjects":["Pathology"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/42577","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/42577","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F42577","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Duffy, Elizabeth"]},{"key":"dc:creator","label":"Author","values":["King, Catherine"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2021-05-20T19:21:19Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2021-05-20T19:21:19Z"]},{"key":"dc:date.issued","label":"Date","values":["2021"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2021-05-15T01:02:50Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Pathology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Pathology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/42577"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Lung cancer is considered one of the deadliest cancers worldwide, with a five-year survival rate of under 20% [8]. There are three different categories of NSCLC tumors: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. The most common of the tumor types is adenocarcinoma [13]. Different cell types that make up the tumor microenvironment contribute to the treatment response and prognosis of the disease. Myeloid-derived suppressor cells (MDSCs) have been shown to be increased in cancer patients compared to healthy individuals. These cells are immunosuppressive and there is evidence that MDSCs play a role in drug resistance, tumor metastases, and suppression of immune cells in cancer [3]. Antigen presenting cells (APCs) are immune cells that present antigens to B cells, macrophages, and dendritic cells. Tumors can become resistant to immunotherapy by evading T cells through modulating antigen presentation by surface MHC (major histocompatibility complex) [7]. APCs use MHC to present antigens and interact with T cells. This interaction influences T cell activation and differentiation [4]. Characterizing differences in MDSCs and APCs between normal lung samples and NSCLC samples may be helpful in identifying mechanisms of tumor progression and treatment resistance. Multiplex IHC (immunohistochemistry) is a useful technique for the identification of MDSCs and APCs and it allows for the visualization of spatial relationships between these cell types and the tumor cells."]},{"key":"dc:title","label":"Title","values":["Using multiplex IHC to identify myeloid derived suppressor cells and antigen presenting cells in NSCLC"]}]}],"canonical_facts":{"dc:contributor.advisor":["Duffy, Elizabeth"],"dc:creator":["King, Catherine"],"dc:date.accessioned":["2021-05-20T19:21:19Z"],"dc:date.available":["2021-05-20T19:21:19Z"],"dc:date.issued":["2021"],"dc:date.updated":["2021-05-15T01:02:50Z"],"dc:description.abstract":["Lung cancer is considered one of the deadliest cancers worldwide, with a five-year survival rate of under 20% [8]. There are three different categories of NSCLC tumors: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. The most common of the tumor types is adenocarcinoma [13]. Different cell types that make up the tumor microenvironment contribute to the treatment response and prognosis of the disease. Myeloid-derived suppressor cells (MDSCs) have been shown to be increased in cancer patients compared to healthy individuals. These cells are immunosuppressive and there is evidence that MDSCs play a role in drug resistance, tumor metastases, and suppression of immune cells in cancer [3]. Antigen presenting cells (APCs) are immune cells that present antigens to B cells, macrophages, and dendritic cells. Tumors can become resistant to immunotherapy by evading T cells through modulating antigen presentation by surface MHC (major histocompatibility complex) [7]. APCs use MHC to present antigens and interact with T cells. This interaction influences T cell activation and differentiation [4]. Characterizing differences in MDSCs and APCs between normal lung samples and NSCLC samples may be helpful in identifying mechanisms of tumor progression and treatment resistance. Multiplex IHC (immunohistochemistry) is a useful technique for the identification of MDSCs and APCs and it allows for the visualization of spatial relationships between these cell types and the tumor cells."],"dc:identifier.uri":["https://hdl.handle.net/2144/42577"],"dc:language.iso":["en_US"],"dc:subject":["Pathology"],"dc:title":["Using multiplex IHC to identify myeloid derived suppressor cells and antigen presenting cells in NSCLC"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Pathology"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T20:28:34Z"}